PolyPid Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Director
Retrieved on:
Monday, July 12, 2021
I am delighted to welcome Dr. Senagore to the PolyPid team as we continue to advance toward commercialization of D-PLEX100, stated Amir Weisberg, CEO of PolyPid.
Key Points:
- I am delighted to welcome Dr. Senagore to the PolyPid team as we continue to advance toward commercialization of D-PLEX100, stated Amir Weisberg, CEO of PolyPid.
- Anthony J. Senagore, M.D., is a colorectal surgeon with a long track record of academic surgery practice and significant experience in healthcare start-up companies.
- In addition, Dr. Senagore has edited five textbooks in colon and rectal surgery and authored over 230 peer-reviewed publications and 25 textbook chapters.
- PolyPid Ltd. (Nasdaq: PYPD ) is a Phase 3 biopharmaceutical company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics.